Transaction · 0001522780-26-000004

Kaye Edward M. MD

Kaye Edward M. MD, DIR, reported a transaction classified as grant at Stoke Therapeutics, Inc. involving 17786.000000 shares for an estimated $0.00. Reported holdings after the transaction were 17786.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
STOKStoke Therapeutics, Inc.
Filing timeJun 05
Trade dateJun 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$30.01
Pre-filing
1mo ago +13.9%1w ago +4.8%1d ago -4.4%
Returns since
7d -0.6%30d +9.0%90d +12.4%180d +12.4%1y +12.4%

STOK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
STOK since 2026-06-05Filed 91 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001522780-26-000004
Director Stock Option (Right to Buy)
Transaction date
Jun 03, 2026
Filed Jun 05, 2026, 08:27 PM · 2d delay
Shares
17.7k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
17.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The option shall vest in full on the earlier of: (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the…

Original filing · 0001522780-26-000004
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

STOK